On the one hand, mPEG masking extends the half‐life and sterically blocks target antigen engagement with low immunogenicity, and on the other hand, unmasked TriTNE binds to dual tumor antigens to overcome TAA heterogeneity and PD‐L1‐mediated immune escape. Here, CD274 is linked to neoplasm.